Authors
Loading...
Survey reveals high out-of-pocket costs faced by multiple myeloma patients, indicating significant financial toxicity linked to co-pay assistance.
Peppercorn et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: